Forte Biosciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for FBRX, updated each market day.
FBRX AI Sentiment
AI predicts Forte Biosciences, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Forte Biosciences, Inc. Common Stock
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Sector
Exchange
Market Cap
$470,724,145
Cap Tier
Employees
19
Headquarters
DALLAS, TX
Listed Since
June 16, 2020
Website
FBRX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FBRX Volatility
Forte Biosciences, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
